The wearable breast pump market has exploded in recent years. In the last three years alone, dozens of new devices have launched, each marketed as more advanced than the last. Features like night lights, stronger suction, electric charging cases, and even massagers and heat are touted as innovations. Yet these enhancements often come from engineers and designers who lack firsthand experience with breastfeeding or an understanding of clinical research on breast milk production.

This approach prioritizes features for investor pitches over practical solutions for nursing mothers. Whether in a nursing room at home, a park, or an employer’s pumping space, the result is often a competition of specs rather than a focus on real user needs.

I know this space intimately—not as an executive with a market map, but as a mother who has faced the limitations of existing products. This perspective revealed a critical truth in consumer tech: there is a meaningful difference between studying your user and being your user. The best products emerge from lived experience, not just empathy.

Empathy alone isn’t enough. Mothers deserve technology that centers their experience, works reliably, and meets rigorous clinical standards. Yet today’s market is flooded with hardware optimized for investor decks, not for real lives or biology. This creates a “gadget trap,” where products are designed to look impressive on paper but fail in practice—sometimes causing discomfort or even unsafe outcomes.

For example, many wearable pumps prioritize being the “thinnest” design. However, this often means they cannot accommodate nipple enlargement during pumping. Paired with extremely strong suction, the result is a product that hurts and is ineffective for most women.

Why the Current Approach Falls Short

The blind spot in this category stems from a persistent assumption: that a growing market alone justifies innovation. Product teams may conduct surveys or focus groups, then hand off design briefs to engineers tasked with creating something “impressive enough” for investors. The outcome? Devices that look good in presentations but underperform—or worse, cause harm.

Real Innovation Requires Rigor and Empathy

True progress in this space demands more than good intentions. It requires:

  • Products designed by people who have lived the problem, not just studied it.
  • Rigorous clinical testing and validation to ensure safety and efficacy.
  • A focus on solving real biological and logistical challenges, not just adding features.

The market for nursing support products is expanding, and with it, the opportunity for meaningful innovation. But meaningful innovation requires a shift from chasing investor approval to solving women’s actual needs. Only then can we move beyond the gadget trap and deliver products that truly support postpartum well-being.